Body Composition Changes During Stem Cell Transplantation: The Case Of Lymphoma Patients
NCT ID: NCT02983643
Last Updated: 2017-05-10
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
105 participants
OBSERVATIONAL
2016-01-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Patient Fitness and Body Composition During Hematopoietic Stem Cell Transplantation
NCT02990130
Physical Impairments in Allogeneic-HSCT
NCT03448627
Evolution of the Energy Expenditure During Hematopoietic Stem Cell Transplantation
NCT04535570
Physical Impairments Related to Myeloid and Lymphoid Malignancies
NCT03699358
Musculoskeletal Outcomes After Bone Marrow Transplant
NCT00558948
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The radiologist will access the AUBMC PACS system to review PET/CT scans of the identified patients. SMI, visceral, subcutaneous and intramuscular adipose tissues will be established by assessing at the level of L3.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients having B and T cell lymphoma who have undergone SCT at AUBMC
Exclusion Criteria
* Patients with 2 missing post SCT PET / CT scan
16 Years
80 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aix Marseille Université
OTHER
American University of Beirut Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Jean El Cheikh, MD
Role: PRINCIPAL_INVESTIGATOR
AUBMC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
American University of Beirut Medical Center
Beirut, , Lebanon
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IM.J-EC.04
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.